Diseases & Disorders
(G12)
IRS Verified
DX Registered
990 on File
GO2 FOUNDATION FOR LUNG CANCER
Financial strength (30%)
77/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Our foundation’s commitment to our patients is to collaborate and partner with the leaders in oncology, technology, science, medicine and philanthropy to make Lung Cancer a chronically managed disease within 10 years. We believe that personalized medicine is the gateway to success and we will power progress by involving patients, donors, clinicians, pharma, biotech, payers, government and public and private enterprise.
Financial Overview — FY 2025
$12.0M
Total Revenue
$12.8M
Total Expenses
$10.7M
Net Assets
63
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
77.6%
Fundraising Efficiency
1386.3%
Operating Reserve
9.96x
Liability-to-Asset
37.1%
Revenue Diversification
97.6%
Executive Compensation
$1.9M
Compared with Peers
FY 2025
Compared with 105 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
77.6% | 85.4% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.4% | 11.1% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
13.1% | 1.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
1386.3% | 368.9% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
10.0 mo | 10.0 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
37.1% | 23.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
97.6% | 92.0% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-2.0% | 7.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-24.2% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-7.1% | 3.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $12.0M | $12.8M | $10.7M | 77.6% | 63 |
| 2024 | $12.2M | $16.9M | $11.5M | 81.7% | 64 |
| 2023 | $12.8M | $13.8M | $16.2M | 79.5% | 62 |
| 2022 | $15.2M | $12.5M | $17.2M | 79.7% | 59 |
| 2021 | $13.8M | $11.7M | $14.4M | 80.8% | 49 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.